CHD1 and pancreatic neoplasm: Western blot analysis along with corresponding quantification data provided below the immunoblotting figures (Fig. 3A) shows that knockdown of hPaf1/PD2 in pancreatic cancer cells leads to a decrease in the level of CHD1 compared to the scrambled control cells.